 | • レポートコード：TPM-B04285 • 出版社/出版日：Transparency Market Research / 2017年11月 • レポート形態：英文、PDF、166ページ • 納品方法：Eメール • 産業分類：製薬・医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、疼痛管理用治療薬の世界市場について調べ、疼痛管理用治療薬の世界規模、市場動向、市場環境、治療薬別分析、疾患別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・疼痛管理用治療薬の世界市場動向 ・疼痛管理用治療薬の世界市場環境 ・疼痛管理用治療薬の世界市場規模 ・疼痛管理用治療薬の世界市場規模：治療薬別 ・疼痛管理用治療薬の世界市場規模：疾患別 ・疼痛管理用治療薬の世界市場：地域別市場規模・分析 ・疼痛管理用治療薬の北米市場規模・予測 ・疼痛管理用治療薬のアメリカ市場規模・予測 ・疼痛管理用治療薬のヨーロッパ市場規模・予測 ・疼痛管理用治療薬のアジア市場規模・予測 ・競争状況・関連企業情報 |
Global Pain Management Therapeutics Market: Overview
This report on the pain management therapeutics market studies the current as well as future prospects of the market globally. The pain management therapeutics market report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the general information and data analysis of the global pain management therapeutics market with respect to the leading market segments based on major therapeutics, and geographies.
Global Pain Management Therapeutics Market: Market Dynamics
The market overview section of the report explores the dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the pain management therapeutics market and could influence the market in the near future. Market attractiveness analysis has been provided in the overview section in order to explain the intensity of competition across different geographies. The competitive scenario among different players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their position and expand their shares in the global pain management therapeutics market.
Global Pain Management Therapeutics Market: Market Segmentation
The global pain management therapeutics market has been studied based on major segments by therapeutics, by indication and their regional as well as national markets. Based on therapeutics, the global market has been segmented into anticonvulsants, antidepressants, anesthetics, non-steroidal anti-inflammatory drugs (NSAIDS), opioids, other non-narcotic analgesic, and antimigraine agents. Further the market has been segmented according to its indication that includes neuropathic pain, fibromyalgia, arthritic pain, chronic back pain, migraine, post-operative pain, and cancer pain. The market for these segments has been extensively analyzed based on their effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn for the period from 2015-2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all segments, considering 2016 as the base year.
Geographically, the pain management therapeutics market has been segmented into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). Each regional pain management therapeutics market has been further categorized into major national markets such as the U.S, Canada, Germany, the U.K., Japan, China, Brazil, and Mexico. Market revenue in terms of US$ Mn for the period from 2015-2025 along with CAGR % from 2017 to 2025 are provided for all the regions and nations considering 2016 as the base year.
Global Pain Management Therapeutics Market: Competitive Landscape
The competition landscape section included in the report would assist existing market players to expand their market shares, and new companies in establishing their presence in the global pain management therapeutics market. The report also profiles key players operating in this market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Pfizer Inc., Depomed, Inc., Endo International plc. , Purdue Pharma L.P., Mallinckrodt Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Abbott Laboratories, GlaxoSmithKline plc., and other prominent players.
The global pain management therapeutics market is segmented as follows:
Global Pain Management Therapeutics Market Revenue, by Therapeutics
Anticonvulsants
Antidepressants
Anesthetics
Non-steroidal Anti-inflammatory Drugs (NSAIDS)
Opioids
Oxycodones
Hydrocodones
Tramadol
Others (Morphine, Codeine, Fentanyl, Meperidine, Methadone)
Antimigraine Agents
Other Non-narcotic Analgesic
Global Pain Management Therapeutics Market Revenue, by Indication
Neuropathic Pain
Fibromyalgia
Chronic Back Pain
Arthritic Pain
Migraine
Post-operative Pain
Cancer Pain
Global Pain Management Therapeutics Market, by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific (APAC)
Japan
China
India
Australia & New Zealand
Rest of APAC
Rest of the World (RoW)
Section 1 Preface
1.1 Report Scope
1.2 Market Segmentation
1.3 Research Highlights
Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Acronyms Used
2.3 Research Methodology
Section 3 Executive Summary
Section 4 Market Overview
4.1 Product Overview
4.2 Key Industry Developments
4.3 Market Opportunity Map
4.4 Porter’s Analysis
4.5 Global Pain Management Therapeutics Market Outlook
Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Trends
5.6 Most Types of Body Pain Location Globally and Cut by Gender and Parents
5.7 Pain Management Therapeutics Pipeline Analysis – Snapshot
5.8 Opioids with FDA-Approved Labeling Describing Abuse-Deterrent Properties
5.9 Global Pain Management Therapeutics Market Value (Revenue)
5.10 Pain Management Therapeutics Market Outlook
Section 6 Pain Management Therapeutics Market Analysis, by Therapeutics Type
6.1 Key Findings
6.2 Introduction
6.3 Global Pain Management Therapeutics Market Value Share Analysis, by Therapeutics Type
6.4 Global Pain Management Therapeutics Market Forecast, by Therapeutics Type
6.4.1 Global Pain Management Therapeutics Market Value Share Analysis, by Opioids
6.4.2 Global Pain Management Therapeutics Market Forecast, by Opioids
6.4.3 Global Anticonvulsants Therapeutics Market, US$ Mn, 2015–2025
6.4.4 Global Antidepressants Therapeutics Market, US$ Mn, 2015–2025
6.4.5 Global Anesthetics Therapeutics Market, US$ Mn, 2015–2025
6.4.6 Global NSAIDs Therapeutics Market, US$ Mn, 2015–2025
6.4.7 Global Opioids Therapeutics Market, US$ Mn, 2015–2025
6.4.8 Global Ant migraine Agents Therapeutics Market, US$ Mn, 2015–2025
6.4.9 Global Other Non-narcotic Analgesics Therapeutics Market, US$ Mn, 2015–2025
6.5 Global Pain Management Therapeutics Market Analysis, by Therapeutics
6.6 Global Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
Section 7 Global Pain Management Therapeutics Market Analysis, by Indication
7.1 Key Findings
7.2 Introduction
7.3 Global Pain Management Therapeutics Market Value Share Analysis, By Indication, 2016 and 2025
7.4 Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, By Indication, 2015–2025
7.4.1 Global Neuropathic Pain Market, US$ Mn, 2015–2025
7.4.2 Global Fibromyalgia Market, US$ Mn, 2015–2025
7.4.3 Global Arthritic Pain Market, US$ Mn, 2015–2025
7.4.4 Global Chronic Back Pain Market, US$ Mn, 2015–2025
7.4.5 Global Migraine Market, US$ Mn, 2015–2025
7.4.6 Global Post-Operative Pain Market, US$ Mn, 2015–2025
7.4.7 Global Cancer Pain Market, US$ Mn, 2015–2025
7.5 Global Pain Management Therapeutics Market Attractiveness By Indication
Section 8 Pain Management Therapeutics Market Analysis, by Region
8.1 Global Scenario, by Country
8.2 Global Pain Management Therapeutics Market Value Share Analysis By Region, 2016 and 2025
8.3 Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, By Region, 2015–2025
8.4 Global Pain Management Therapeutics Market Attractiveness Analysis, by Region
Section 9 North America Pain Management Therapeutics Market Analysis
9.1 Key Findings
9.2 North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017–2025
9.3 North America Market Attractiveness Analysis, by Country
9.4 North America Market Value Share Analysis, by Country, 2017 and 2025
9.5 North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country Type, 2015–2025
9.4 North America Market Value Share Analysis, by Therapeutics, 2017 and 2025
9.5 North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics Type, 2015–2025
9.5.1 North America Pain Management Therapeutics Market Value Share Analysis, by Opioids
9.5.2 North America Pain Management Therapeutics Market Forecast, by Opioids
9.6 North America Market Value Share Analysis, by Indication, 2017 and 2025
9.7 North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015–2025
9.8 North America Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
9.9 North America Pain Management Therapeutics Market Attractiveness Analysis, by Indication
Section 10 Europe Pain Management Therapeutics Market Analysis
10.1 Key Findings
10.2 Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017–2025
10.3 Europe Market Attractiveness Analysis, by Country
10.4 Europe Market Value Share Analysis, by Country, 2017 and 2025
10.5 Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country Type, 2015–2025
10.5.1 Europe Pain Management Therapeutics Market Value Share Analysis, by Opioids
10.5.2 Europe Pain Management Therapeutics Market Forecast, by Opioids
10.6 Europe Market Value Share Analysis, by Indication, 2017 and 2025
10.7 Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015–2025
10.8 Europe Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
10.9 Europe Pain Management Therapeutics Market Attractiveness Analysis, by Indication
Section 11 Asia Pacific Pain Management Therapeutics Market Analysis
11.1 Key Findings
11.2 Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017–2025
11.3 Asia Pacific Market Attractiveness Analysis, by Country
11.4 Asia Pacific Market Value Share Analysis, by Country, 2017 and 2025
11.5 Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country Type, 2015–2025
11.5.1 Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Opioids
11.5.2 Asia Pacific Pain Management Therapeutics Market Forecast, by Opioids
11.6 Asia Pacific Market Value Share Analysis, by Indication, 2017 and 2025
11.7 Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015–2025
11.8 Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
11.9 Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Indication
Section 12 Rest of the World Pain Management Therapeutics Market Analysis
12.1 Key Findings
12.2 Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017–2025
12.3 Rest of the World Market Value Share Analysis, by Therapeutics, 2017 and 2025
12.4 Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics Type, 2015–2025
12.4.1 Rest of the World Pain Management Therapeutics Market Value Share Analysis, by Opioids
12.4.2 Rest of the World Pain Management Therapeutics Market Forecast, by Opioids
12.5 Rest of the World Market Value Share Analysis, by Indication, 2017 and 2025
12.6 Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015–2025
12.7 Rest of the World Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
12.8 Rest of the World Pain Management Therapeutics Market Attractiveness Analysis, by Indication
Section 13 Competition Landscape
13.1 Competition Matrix
13.2 Heat Map Analysis
13.3 Company Profiles
13.3.1 Pfizer Inc.
13.3.1.1 Company Details
13.3.1.2 Business Overview
13.3.1.3 Financial Overview
13.3.1.4 Strategic Overview
13.3.1.5 SWOT Analysis
13.3.2 Depomed, Inc.
13.3.2.1 Company Details
13.3.2.2 Business Overview
13.3.2.3 Financial Overview
13.3.2.4 Strategic Overview
13.3.2.5 SWOT Analysis
13.3.3 Endo International plc.
13.3.3.1 Company Details
13.3.3.2 Business Overview
13.3.3.3 Financial Overview
13.3.3.4 Strategic Overview
13.3.3.5 SWOT Analysis
13.3.4 Purdue Pharma L.P.
13.3.4.1 Company Details
13.3.4.2 Business Overview
13.3.4.3 Financial Overview
13.3.4.4 Strategic Overview
13.3.4.5 SWOT Analysis
13.3.5 Mallinckrodt Pharmaceuticals
13.3.5.1 Company Details
13.3.5.2 Business Overview
13.3.5.3 Financial Overview
13.3.5.4 Strategic Overview
13.3.5.5 SWOT Analysis
13.3.6 Teva Pharmaceutical Industries Ltd.
13.3.6.1 Company Details
13.3.6.2 Business Overview
13.3.6.3 Financial Overview
13.3.6.4 Strategic Overview
13.3.6.5 SWOT Analysis
13.3.7 Novartis AG
13.3.7.1 Company Details
13.3.7.2 Business Overview
13.3.7.3 Financial Overview
13.3.7.4 Strategic Overview
13.3.7.5 SWOT Analysis
13.3.8 AstraZeneca plc.
13.3.8.1 Company Details
13.3.8.2 Business Overview
13.3.8.3 Financial Overview
13.3.8.4 Strategic Overview
13.3.8.5 SWOT Analysis
13.3.9 Johnson & Johnson Services, Inc.
13.3.9.1 Company Details
13.3.9.2 Business Overview
13.3.9.3 Financial Overview
13.3.9.4 Strategic Overview
13.3.9.5 SWOT Analysis
13.3.10 Merck & Co., Inc.
13.3.10.1 Company Details
13.3.10.2 Business Overview
13.3.10.3 Financial Overview
13.3.10.4 Strategic Overview
13.3.10.5 SWOT Analysis
13.3.11 Abbott Laboratories
13.3.11.1 Company Details
13.3.11.2 Business Overview
13.3.11.3 Financial Overview
13.3.11.4 Strategic Overview
13.3.11.5 SWOT Analysis
13.3.12 GlaxoSmithKline plc.
13.3.11.1 Company Details
13.3.11.2 Business Overview
13.3.11.3 Financial Overview
13.3.11.4 Strategic Overview
13.3.11.5 SWOT Analysis
Table 01: Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 02: Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Opioids, 2015–2025
Table 03: Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 04: Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country, 2015– 2025
Table 06: North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 07: North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Opioids, 2015– 2025
Table 08: North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015– 2025
Table 09: Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 10: Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 11: Europe Pain Management Therapeutics Market Revenue (US$ Mn) Forecast, by Opioids, 2015–2025
Table 12: Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 13: Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 14: Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015– 2025
Table 15: Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Opioids, 2015–2025
Table 16: Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 17: Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
Table 18: Rest of the World Opioids Market Revenue, by Therapeutic, (US$ Mn), 2015–2025
Table 19: Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 20: List of Other Prominent Players
Table 21: List of Other Prominent Players
Table 22: List of Other Prominent Players